Intraseasonal waning immunity of seasonal influenza vaccine - A systematic review and meta-analysis.

[1]  C. Macintyre,et al.  Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage. , 2019, Vaccine.

[2]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[3]  C. Reed,et al.  Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  I. Barr,et al.  Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Kulldorff,et al.  Intra-season Waning of Influenza Vaccine Effectiveness. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Stockwell,et al.  Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States. , 2018, Vaccine.

[7]  A. Wilder-Smith,et al.  Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies , 2018, The Journal of infectious diseases.

[8]  M. Tortajada-Girbés,et al.  Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. , 2017, Vaccine.

[9]  Edward A Belongia,et al.  Repeated annual influenza vaccination and vaccine effectiveness: review of evidence , 2017, Expert review of vaccines.

[10]  A. Cook,et al.  Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. , 2017, Vaccine.

[11]  B. Flannery,et al.  Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015 , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  T. Braun,et al.  Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season. , 2016, The Journal of infectious diseases.

[13]  Fengji Luo,et al.  Immunological persistence of a seasonal influenza vaccine in people more than 3 years old , 2015, Human vaccines & immunotherapeutics.

[14]  A. Monto,et al.  Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. , 2015, The Journal of infectious diseases.

[15]  Sanjay S. Patel,et al.  Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children. , 2014, Vaccine.

[16]  R. Couch,et al.  Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older , 2014, BMC Infectious Diseases.

[17]  O. Ofori-Anyinam,et al.  Vaccine for prevention of mild and moderate-to-severe influenza in children. , 2013, The New England journal of medicine.

[18]  T. Vesikari,et al.  Oil-in-water emulsion adjuvant with influenza vaccine in young children. , 2011, The New England journal of medicine.

[19]  A. Whitehead,et al.  Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials , 2009, Clinical trials.

[20]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .